Analysts expect over 2019 rising revenue Abbott

Tomorrow Abbott will publish it's past quarters results. For this year Abbott's revenue will be around 31.94 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2018's revenue of 30.58 billion USD.

Historical revenues and results Abbott plus estimates 2019

financial analysis

The analysts expect for 2019 a net profit of 5.79 billion USD. For this year the consensus of the result per share is a profit of 3.24 USD. So the price/earnings-ratio equals 24.64.

For this year the analysts expect a dividend of 1.26 USD per share. Abbott's dividend yield thus equals 1.58 percent. The average dividend yield of the pharmaceutical companies equals a low 0.5 percent.

Abbott's market capitalization is based on the number of outstanding shares around 139.17 billion USD. The Abbott stock was the past 12 months quite unstable. Since last October the stock is 18 percent higher. This year the stock price moved between 65 and 89 dollar.

Historical stock prices Abbott2007-2019

financial analysis abbott

Click here for dividend . At 0.30 the stock trades 0 percent lower at 79.82 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.